12:00 AM
Oct 18, 1999
 |  BC Week In Review  |  Clinical News  |  Clinical Status

Beclomethasone Spiros: Began Phase III testing

Dura Pharmaceuticals Inc. (DURA), San Diego, Calif.
Product: Beclomethasone Spiros
Business: Autoimmune/Inflammation, Pulmonary
Therapeutic category: Immune suppression
Target: Immune...

Read the full 74 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >